Overexpression of AKR1B10 was seen in cancers of the lungs and liver associated with a less aggressive clinical course, whereas AKR1B1 was more widely overexpressed in several cancers and associated with shortened patient survival. This evidence concerns the gene AKR1B1 and cancer.